Khoi started selling phones and accessories in Soweto. Today the company operates under Khoi Tech and Khoi Afripods, chasing a very different prize: AI-powered healthcare solutions for South Africans who cannot afford private specialists.
From Retail Shelves to Algorithm Labs
The pivot was not planned. Khoi found that customers kept asking the same question during gadget purchases: could technology help them monitor chronic conditions without visiting a clinic? That question reshaped the entire business model. Khoi Afripods became the consumer-facing brand, while Khoi Tech now develops the backend systems that power diagnostic support tools.
The shift required hiring data scientists and medical consultants — a costly move for a company that once measured success by phone case sales. Yet the bet reflects a wider trend in South African entrepreneurship: underserved healthcare markets are attracting talent that previously chased fintech or e-commerce.
Why Investors Are Paying Attention
Venture capital flowing into South African healthtech reached notable levels over the past two years, according to industry trackers. Khoi is not alone in sensing the opportunity. Competitors like Quro Medical and HearX Group have raised substantial rounds by targeting similar gaps in primary care access.
What makes Khoi stand out is its origins. Rather than launching from a Sandton office park, the company built its customer base in a township where healthcare infrastructure remains stretched. That geographic advantage gives Khoi direct access to the patients that national schemes and medical aids are struggling to reach.
The Funding Question
Khoi has not disclosed total funding raised. The company confirmed it is in active talks with two Johannesburg-based investment firms but declined to name them pending formal announcements. Sources familiar with the discussions suggest the talks centre on a pre-Series A round that would fund expansion into Gauteng and KwaZulu-Natal.
South Africa's government has signalled interest in digital health through the National AI Plan, which identifies healthcare as a priority sector. Whether that translates into grants or procurement contracts for startups like Khoi remains unclear.
What This Means for the Broader Economy
Healthtech pivots carry weight beyond individual companies. South Africa faces a dual burden: a growing population requiring chronic disease management and a public system that creaks under resource constraints. AI tools that triage patients or flag early warning signs could reduce pressure on clinics while generating data that informs public health planning.
The economic argument is straightforward. Every avoided hospital admission saves the state money. Every diagnostic tool that works on a smartphone removes a transport cost for a rural patient. Khoi and its peers are betting that this arithmetic will attract both capital and government willingness to integrate their products into public health streams.
Risks on the Road Ahead
Regulatory hurdles represent the most immediate challenge. Health AI products must clear approval processes that were designed for pharmaceuticals and medical devices, not software. Khoi will need to demonstrate clinical validation — a time-consuming and expensive requirement for a company still building revenue.
Data privacy adds another layer. Collecting patient information in South Africa triggers compliance obligations under the Protection of Personal Information Act. Any breach or accusation of misuse could derail partnerships with hospitals and medical schemes before they begin.
The Township Advantage
Soweto carries symbolic weight in South African business narratives. Companies that succeed there are often seen as having cracked the market that mainstream providers ignore. Khoi leans into that positioning deliberately, referencing proximity to customers in marketing materials and investor pitches alike.
That approach resonates with development finance institutions and impact investors seeking measurable social outcomes alongside financial returns. Khoi's model — serving patients who would otherwise go without — checks boxes that pure commercial healthcare ventures cannot.
What Happens Next
Khoi plans to launch a pilot programme with three community health centres in Soweto before the end of the current quarter. Results from that rollout will determine whether the company can secure the investment round it needs to scale. If the pilot performs as projected, Khoi expects to announce a formal partnership with a national pharmacy chain by mid-year.
Investors and competitors alike will be watching those numbers closely. Khoi's journey from gadget shop to healthtech hopeful illustrates the opportunities opening up across South Africa's healthcare sector — and the stakes involved in getting the formula right.
See Also
- Maharashtra Introduces Stricter Rules for Religious Conversions
- Antetokounmpo shatters records again: what it means for the Bucks and Africa
Khoi leans into that positioning deliberately, referencing proximity to customers in marketing materials and investor pitches alike.That approach resonates with development finance institutions and impact investors seeking measurable social outcomes alongside financial returns. Every diagnostic tool that works on a smartphone removes a transport cost for a rural patient.
